Investors
EQL Pharma develops, sells and markets medicines with a focus on niche products having no patent protection. The company currently has a smaller portfolio on the market and an extensive pipeline of unique medicines. EQL Pharma strives to maintain an open and proactive dialogue with current and potential shareholders and to give the market and society a good insight into and understanding of our business.
Stock Information
Financial Report
Financial Calendar
Presentations
Financial Reports
2014
Annual Report 2014
2013
Annual Report 2013
2011
Annual Report 2011
2010
Annual Report 2010
2009
Annual Report 2009
2008
Annual Report 2008
2007
Annual Report 2007
Financial Calendar
17
November 2023
- Half-yearly report Q2
13
February 2024
- Interim report Q3
14
May 2024
- Year end report Q4